Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT Jr, Lu D, Paulson EK, Schwartz LH, Siegelman ES, Small WC, Weber TM, Welber A, Shamsi K.
Bluemke DA, et al. Among authors: welber a.
Radiology. 2005 Oct;237(1):89-98. doi: 10.1148/radiol.2371031842. Epub 2005 Aug 26.
Radiology. 2005.
PMID: 16126918